MitoP Cancer Research Results
MitoP, Mitophagy: Click to Expand ⟱
| Source: |
| Type: |
Mitophagy—the selective autophagic removal of damaged mitochondria—is now regarded as a core upstream process in Alzheimer’s disease pathophysiology, not a secondary epiphenomenon. Impairment of mitophagy precedes overt amyloid and tau pathology and helps explain early synaptic failure and neuronal vulnerability.
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
ostP, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
*MitoP↓, *Strength↑, *PINK1↑, *PARK2↑, *Inflam↓, *COX2↓, *IL1β↓, *IL6↓, *TNF-α↓, *OS↑, *cardioP↑, *memory↑, *neuroG↑, *neuroP↑, *Cartilage↑, *Inflam↓, *RenoP↑, *eff↑, *Dose↝, *Half-Life↑, *NRF2↑, *GutMicro↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Total Targets: 0
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
NRF2↑, 1, PARK2↑, 1,
Mitochondria & Bioenergetics ⓘ
PINK1↑, 1,
Autophagy & Lysosomes ⓘ
MitoP↓, 1,
Proliferation, Differentiation & Cell State ⓘ
neuroG↑, 1,
Migration ⓘ
Cartilage↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL1β↓, 1, IL6↓, 1, Inflam↓, 2, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
Dose↝, 1, eff↑, 1, Half-Life↑, 1,
Clinical Biomarkers ⓘ
GutMicro↑, 1, IL6↓, 1,
Functional Outcomes ⓘ
cardioP↑, 1, memory↑, 1, neuroP↑, 1, OS↑, 1, RenoP↑, 1, Strength↑, 1,
Total Targets: 22
Scientific Paper Hit Count for: MitoP, Mitophagy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1406 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page